Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03321019 · ClinicalTrials.gov registry record
Airway Protective Mechanisms in PD (R01)
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 119
- Enrollment target
NCT03321019 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 119 participants.
The verdict
NCT03321019 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
This study will collect data on various aspects of airway sensation and function, and determine how it relates to the development of swallowing and cough dysfunction in Parkinson's disease. Participants will be followed over a 3-year period, with once-per-year visits to collect the data.
Interventions
- DRUG Capsaicin
- DEVICE Resistive respiratory loads
- OTHER Event-related evoked potential using electroencephalography (EEG).
- PROCEDURE Fluoroscopic swallow evaluation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2017-12-12 |
| Est. Completion | 2023-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03321019
The ClinicalTrials.gov registry entry for NCT03321019 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Capsaicin is the first listed.
NCT03321019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03321019 about?
NCT03321019 is a clinical study titled "Airway Protective Mechanisms in PD (R01)". This study will collect data on various aspects of airway sensation and function, and determine how it relates to the development of swallowing and cough dysfunction in Parkinson's disease. Participants will be followed over a 3-year period, with once-per-year visits to collect the data.
What is the current status of trial NCT03321019?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2017-12-12. Estimated completion is 2023-09-29.
What interventions are being tested in trial NCT03321019?
The interventions under investigation include: Capsaicin (DRUG), Resistive respiratory loads (DEVICE), Event-related evoked potential using electroencephalography (EEG). (OTHER), Fluoroscopic swallow evaluation (PROCEDURE).
Who is sponsoring clinical trial NCT03321019?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.